Report cover image

Joint Pain Injections Market Size , Industry, Share, Analysis, Trends and Global Forecast 2024 - 2032

Publisher Acumen Research and Consulting
Published Jun 01, 2024
Length 250 Pages
SKU # ACRC19838271

Description

The Joint Pain Injections Market Size accounted for USD 5.8 Billion in 2023 and is estimated to achieve a market size of USD 12.4 Billion by 2032 growing at a CAGR of 8.9% from 2024 to 2032.

The Joint Pain Injections Market has witnessed significant growth in recent years, driven by the increasing prevalence of joint-related disorders, the aging global population, and advancements in injection-based therapies. Joint pain, often associated with conditions such as osteoarthritis, rheumatoid arthritis, and sports-related injuries, has become one of the leading causes of disability worldwide. As a result, the demand for effective treatments to manage joint pain, enhance mobility, and improve the quality of life for patients has escalated. Joint pain injections, including corticosteroids, hyaluronic acid, platelet-rich plasma (PRP), and biologic therapies, have become key solutions for individuals seeking relief from chronic joint pain, offering both short-term and long-term benefits.

Joint Pain Injections Market Segmentation

The worldwide market for joint pain injections is split based on type, joint type product, and geography.

Joint Pain Injection Types
Hyaluronic Acid Injections
Corticosteroid Injections
Interleukin Inhibitors
Platelet-rich Plasma Injections
Other (Steroid Joint Injections, Placental tissue matrix (PTM) Injections, etc.)

Joint Pain Injection Joint Types

Knee and Ankle
Shoulder and Elbow
Hip Joint
Hand and Wrist
Facet Joints of the Spine

Joint Pain Injection Distribution Channels

Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

Joint Pain Injections Market Regional Outlook

North America

U.S.
Canada

Europe

U.K.
Germany
France
Spain
Rest of Europe

Asia-Pacific

India
Japan
China
Australia
South Korea
Rest of Asia-Pacific

Latin America

Brazil
Mexico
Rest of Latin America

The Middle East & Africa

South Africa
GCC Countries
Rest of the Middle East & Africa (ME&A)

Joint Pain Injections Market Players

Some of the top joint pain injections companies offered in our report include Pfizer, Anika Therapeutics, Sanofi, Zimmer Biomet Holdings, Bioventus, Flexion Therapeutics, SEIKAGAKU CORPORATION, Ferring, Chugai Pharmaceutical, and Allergan.

Table of Contents

250 Pages
CHAPTER 1. Industry Overview of Joint Pain Injections Market
1.1. Definition and Scope
1.2. Summary
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Type
2.2.1. Secondary Types
2.2.2. Primary Types
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.2. Restraints and Challenges
3.3. Growth Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Market Concentration Ratio and Market Maturity Analysis of Joint Pain Injections Market
3.6. Technological Roadmap for Joint Pain Injections Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2023
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2023
4.2. R&D Status of Major Manufacturers in 2023
CHAPTER 5. Joint Pain Injections Market By Type
5.1. Introduction
5.2. Joint Pain Injections Revenue By Type
5.2.1. Joint Pain Injections Revenue (USD Million) and Forecast, By Type, 2020-2032
5.2.2. Hyaluronic Acid Injections
5.2.2.1. Hyaluronic Acid Injections Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3. Corticosteroid Injections
5.2.3.1. Corticosteroid Injections Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4. Interleukin Inhibitors
5.2.4.1. Interleukin Inhibitors Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.5. Platelet-rich Plasma Injections
5.2.5.1. Platelet-rich Plasma Injections Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.6. Other (Steroid Joint Injections, Placental tissue matrix (PTM) Injections, etc.)
5.2.6.1. Other (Steroid Joint Injections, Placental tissue matrix (PTM) Injections, etc.) Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 6. Joint Pain Injections Market By Joint Type
6.1. Introduction
6.2. Joint Pain Injections Revenue By Joint Type
6.2.1. Joint Pain Injections Revenue (USD Million) and Forecast, By Joint Type, 2020-2032
6.2.2. Knee and Ankle
6.2.2.1. Knee and Ankle Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3. Shoulder and Elbow
6.2.3.1. Shoulder and Elbow Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.4. Hip Joint
6.2.4.1. Hip Joint Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.5. Hand and Wrist
6.2.5.1. Hand and Wrist Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.6. Facet Joints of the Spine
6.2.6.1. Facet Joints of the Spine Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 7. Joint Pain Injections Market By Distribution Channel
7.1. Introduction
7.2. Joint Pain Injections Revenue By Distribution Channel
7.2.1. Joint Pain Injections Revenue (USD Million) and Forecast, By Distribution Channel, 2020-2032
7.2.2. Hospital Pharmacies
7.2.2.1. Hospital Pharmacies Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.3. Online Pharmacies
7.2.3.1. Online Pharmacies Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.4. Retail Pharmacies
7.2.4.1. Retail Pharmacies Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 8. North America Joint Pain Injections Market By Country
8.1. North America Joint Pain Injections Market Overview
8.2. U.S.
8.2.1. U.S. Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032
8.2.2. U.S. Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032
8.2.3. U.S. Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
8.3. Canada
8.3.1. Canada Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032
8.3.2. Canada Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032
8.3.3. Canada Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
8.4. North America PEST Analysis
CHAPTER 9. Europe Joint Pain Injections Market By Country
9.1. Europe Joint Pain Injections Market Overview
9.2. U.K.
9.2.1. U.K. Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032
9.2.2. U.K. Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032
9.2.3. U.K. Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
9.3. Germany
9.3.1. Germany Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032
9.3.2. Germany Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032
9.3.3. Germany Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
9.4. France
9.4.1. France Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032
9.4.2. France Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032
9.4.3. France Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
9.5. Spain
9.5.1. Spain Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032
9.5.2. Spain Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032
9.5.3. Spain Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
9.6. Rest of Europe
9.6.1. Rest of Europe Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032
9.6.2. Rest of Europe Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032
9.6.3. Rest of Europe Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Joint Pain Injections Market By Country
10.1. Asia Pacific Joint Pain Injections Market Overview
10.2. China
10.2.1. China Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032
10.2.2. China Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032
10.2.3. China Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.3. Japan
10.3.1. Japan Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032
10.3.2. Japan Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032
10.3.3. Japan Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.4. India
10.4.1. India Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032
10.4.2. India Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032
10.4.3. India Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.5. Australia
10.5.1. Australia Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032
10.5.2. Australia Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032
10.5.3. Australia Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.6. South Korea
10.6.1. South Korea Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032
10.6.2. South Korea Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032
10.6.3. South Korea Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032
10.7.2. Rest of Asia-Pacific Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032
10.7.3. Rest of Asia-Pacific Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Joint Pain Injections Market By Country
11.1. Latin America Joint Pain Injections Market Overview
11.2. Brazil
11.2.1. Brazil Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032
11.2.2. Brazil Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032
11.2.3. Brazil Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
11.3. Mexico
11.3.1. Mexico Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032
11.3.2. Mexico Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032
11.3.3. Mexico Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
11.4. Rest of Latin America
11.4.1. Rest of Latin America Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032
11.4.2. Rest of Latin America Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032
11.4.3. Rest of Latin America Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Joint Pain Injections Market By Country
12.1. Middle East & Africa Joint Pain Injections Market Overview
12.2. GCC
12.2.1. GCC Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032
12.2.2. GCC Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032
12.2.3. GCC Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
12.3. South Africa
12.3.1. South Africa Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032
12.3.2. South Africa Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032
12.3.3. South Africa Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Joint Pain Injections Revenue (USD Million) and Forecast By Type, 2020-2032
12.4.2. Rest of Middle East & Africa Joint Pain Injections Revenue (USD Million) and Forecast By Joint Type, 2020-2032
12.4.3. Rest of Middle East & Africa Joint Pain Injections Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Joint Pain Injections Market
13.1. Joint Pain Injections Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Joint Pain Injections Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. Pfizer
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (USD Million), 2023
14.1.3.2. Pfizer 2023 Joint Pain Injections Business Regional Distribution
14.1.4. Product /Service and Specification
14.1.5. Recent Developments & Business Strategy
14.2. Anika Therapeutics
14.3. Sanofi
14.4. Zimmer Biomet Holdings
14.5. Bioventus
14.6. Flexion Therapeutics
14.7. SEIKAGAKU CORPORATION
14.8. Ferring
14.9. Chugai Pharmaceutical
14.10. Allergan

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us